Search results for "Prostate Cancer"


 
Results 31 - 40 of about 109 for "Prostate Cancer".

Letters to the Editor

An Annals of Internal Medicine editorial in the May 5 issue again notes that, “Within 10 years of trial entry, screening increases the number of cancer cases diagnosed but has no ... by overzealous therapies and like to pronounce themselves as
June 2009

Prostate cancer

31, 2015. The study's primary outcomes were prostate cancer-specific mortality and mortality from other causes. ... Hazard ratios for prostate cancer mortality did not appear to vary substantially by clinical stage or primary therapy.
March 2019

FDA approves generic hypertension drugs, looks at Stalevo

because of shortages of propofol injection. The FDA is currently studying whether Stalevo, a Parkinson's disease medication, is associated with an increased risk for developing prostate cancer. ... Researchers unexpectedly found that more patients taking
June 2010

Highlights

Validated tools such as the Expanded Prostate Cancer Index Composite for Clinical Practice may help. ... comprehensive measures of prostate cancer such as the Expanded Prostate Cancer Index Composite for Clinical Practice (EPIC-CP).
June 2014

Highlights

population-based case-control study of men who were diagnosed with prostate cancer in 2007-2009. ... Risk for prostate cancer was the main outcome measure. The study results were published online by BMJ on June 18.
June 2013

New guidance urges caution on testosterone

Similarly, there is no clear guidance on whether it's safe to treat men who have been successfully treated for prostate cancer, said Dr. ... Elghonemy. “Patients who have undergone prostate cancer treatment often have complaints of sexual dysfunction,
May 2020

Highlights

Men with localized, low-risk prostate cancer should be closely monitored until disease progression warrants treatment, concluded an independent panel of the National Institutes of Health. ... Using this definition, the panel estimated that more than
December 2011

Letters to the Editor

Prostate cancer screening leads to unneeded treatments, “ ACP InternistWeekly, March 24. ... And a comment from the body of the article is revealing: “The cumulative death rate from prostate cancer at 10 years in the two groups combined was 25% lower
May 2009

Prostate cancer

The number of men 50 years and older diagnosed with prostate cancer nationwide declined from 213,562 men in 2011 to 180,043 men in 2012. ... An editorial noted concerns about the decline in prostate cancer screening and prostate cancer incidence.
November 2015

Propoxyphene withdrawn, bevacizumab loses indication

In trials of patients with breast and prostate cancer, denosumab increased the length of time to SRE compared to zoledronic acid (Zometa). ... The breast cancer indication for bevacizumab was approved in February 2008 under the FDA's accelerated approval
February 2011

Prev   1   2   3   4   5   6   7   8   9   10   Next